<DOC>
	<DOCNO>NCT01072578</DOCNO>
	<brief_summary>The primary objective study assess effect dapagliflozin amount glucose blood urine dapagliflozin administer day ( 10 mg ) versus twice day ( 5 mg every 12 hour ) five day dose .</brief_summary>
	<brief_title>A Study Assess Effect Dapagliflozin When Administered Once Day Versus Twice Day Blood Glucose</brief_title>
	<detailed_description />
	<criteria>Female healthy volunteer must postmenopausal ( cessation menses &gt; 1year , surgically sterile ( document ) undergone hysterectomy ) sexually abstinent enrolment followup examination Have normal physical exam , vital sign ECG finding , laboratory value Use prescription medication chronic acute medical condition within 3 week randomization History presence neurological , haematological , psychiatric , gastrointestinal , hepatic renal disease , condition know interfere absorption , distribution , metabolism excretion drug determine Investigator Previous participation AstraZeneca ( AZ ) BristolMyers Squibb ( BMS ) dapagliflozin study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Healthy volunteer</keyword>
	<keyword>Inhibition glucose re-absorption</keyword>
	<keyword>diabetes</keyword>
	<keyword>dapagliflozin</keyword>
</DOC>